# A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)

> **NCT02416258** · PHASE2 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 50 (actual)

## Conditions studied

- Skin and Connective Tissue Diseases

## Interventions

- **DRUG:** LP0113 aerosol spray
- **DRUG:** Aerosol spray vehicle
- **DRUG:** LEO 90100 aerosol foam
- **DRUG:** Betamethasone dipropionate aerosol spray
- **DRUG:** Calcipotriol aerosol spray
- **DRUG:** Daivobet® gel

## Key facts

- **NCT ID:** NCT02416258
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02416258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02416258, "A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02416258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*